Adma Biologics Inc. ADMA
$8.68
▼ -1.32% 24H
About
ADMA Biologics Inc. is a biopharmaceutical company that develops, manufactures, and markets specialty plasma-derived biologics for treating immune deficiencies and infectious diseases in the United States and internationally. Its primary products include BIVIGAM and ASCENIV, both intravenous immune globulin (IVIG) ther…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees640
TickerADMA
Statistics
Market Cap$2.02B
Revenue (TTM)$510.2M
Net Income$146.9M
Net Margin28.8%
EPS$0.60
P/E12.24
P/S3.78
P/B4.95
EV/EBITDA203.49
ROE43.3%
Dividend Yield—
Price$8.68
Data: Twelve Data · Revenue = mcap / P/S